Subscribe today for full access on your desktop, tablet, and mobile device. <\/p>\n
Let friends in your social network know what you are reading about <\/p>\n
A noted cancer research has joined AstraZeneca's board of directors. <\/p>\n
Try Another <\/p>\n
Audio CAPTCHA <\/p>\n
Image CAPTCHA <\/p>\n
Help <\/p>\n
CancelSend <\/p>\n
A link has been sent to your friend's email address. <\/p>\n
A link has been posted to your Facebook feed. <\/p>\n
NextFab, a membership-based business, opened Wednesday in Wilmington and offers creators a place to make anything you want with tools ranging from a 3-D printer to wood cutting materials. 6\/14\/17 Damian Giletto\/The News Journal <\/p>\n
1 of 7 <\/p>\n
Ralph Lashley, who recently turned 90, continues to work 40-50 hours a week at Shellhorn & Hill Inc. in Wilmington. 6\/12\/17 Damian Giletto\/The News Journal <\/p>\n
2 of 7 <\/p>\n
View of the new Resilient Tunnel Plug built by ILC Dover. The Resilient Tunnel Plug is capable of blocking tunnels during terrorist attacks and natural disasters. Jason Minto\/The News Journal\/USA TODAY <\/p>\n
3 of 7 <\/p>\n
Tourists may have a harder time finding a beach rental close to the ocean. Several coastal towns report the number of rental licenses are falling. Wochit <\/p>\n
4 of 7 <\/p>\n
Mug & Spoon in Rehoboth Beach where they make monster milkshakes and funky coffee drinks. Jason Minto\/The News Journal\/USA TODAY <\/p>\n
5 of 7 <\/p>\n
The Dover Towne Center is being offered for sale and could fetch as much as $25 million. Jeff Mordock\/The News Journal\/WOCHIT <\/p>\n
6 of 7 <\/p>\n
Dolle's prepared for 90th year at Rehoboth location Jason Minto\/The News Journal\/USA TODAY <\/p>\n
7 of 7 <\/p>\n
Work space for creators opens in Wilmington <\/p>\n
90-year-old man continues full time work schedule <\/p>\n
ILC Dover develops big plug with an even bigger job <\/p>\n
Beach rental licenses fall in some towns <\/p>\n
Fire & ice: funky coffee and ice cream drinks at the beach <\/p>\n
Dover Towne Center up for sale <\/p>\n
Dolle's prepared for 90th year at Rehoboth location <\/p>\n
AstraZeneca is betting big on its cancer oncology portfolio.(Photo: The News Journal File)Buy Photo <\/p>\n
AstraZeneca has named cancer researcher Nazneen Rahman to its board of directors, effective June 1. <\/p>\n
Rahman will serve as a non-executive director and will also become a member of the company's Science Committee. <\/p>\n
Currently, Rahman is the head of the Division of Genetics and Epidemiology at the Institute of Cancer Research in London, head of the Cancer Genetics Unit at the Royal Marsden NHS Foundation Trustand director of the TGL Clinical Gene Testing Laboratory at the Institute of Cancer Research. <\/p>\n
\"We are delighted to welcome Professor Rahman to our Board and Science Committee,\" said Leif Johansson, chairman of AstraZeneca. \"She brings world-renowned expertise in genetic research with a focus on cancer, which is a strategic therapy for our business.\" <\/p>\n
Rahmanhas a degree in medicine from Oxford University and holds a doctorate in molecular genetics. Her research focuses on genes predisposed to cancer, and she has discovered genes that cause types of breast, ovarian and childhood cancers. <\/p>\n
Elected as a fellow of the Academy of Medical Sciences in 2010, Rahman is a member of the scientific advisory boards of Genomics Plc and the Centre for Molecular Medicine Norway, as well as the advisory board of Wellcome Open Research. <\/p>\n
Contact Jeff Mordock at (302) 324-2786, on Twitter @JeffMordockTNJ orjmordock@delawareonline.com<\/a>. <\/p>\n Read or Share this story: http:\/\/www.delawareonline.com\/story\/money\/business\/delawareinc\/2017\/06\/16\/famed-cancer-researcher-joins-astrazenecas-board\/403707001\/<\/a> <\/p>\n 3:01 <\/p>\n 1:36 <\/p>\n 3:16 <\/p>\n 2:14 <\/p>\n 0:59 <\/p>\n 1:47 <\/p>\n 2:07 <\/p>\n 0:57 <\/p>\n 2:19 <\/p>\n 0:33 <\/p>\n <\/p>\n See the article here: <\/p>\n Famed cancer researcher joins AstraZeneca's board - The News Journal<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Subscribe today for full access on your desktop, tablet, and mobile device. Let friends in your social network know what you are reading about A noted cancer research has joined AstraZeneca's board of directors. Try Another Audio CAPTCHA Image CAPTCHA Help CancelSend A link has been sent to your friend's email address Continue reading